A detailed history of Raymond James & Associates transactions in Johnson & Johnson stock. As of the latest transaction made, Raymond James & Associates holds 6,864,404 shares of JNJ stock, worth $1.07 Billion. This represents 0.69% of its overall portfolio holdings.

Number of Shares
6,864,404
Previous 6,267,420 9.53%
Holding current value
$1.07 Billion
Previous $916 Million 21.44%
% of portfolio
0.69%
Previous 0.61%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$145.48 - $167.38 $86.8 Million - $99.9 Million
596,984 Added 9.53%
6,864,404 $1.11 Billion
Q2 2024

Jul 19, 2024

SELL
$144.38 - $157.78 $16.9 Million - $18.4 Million
-116,921 Reduced 1.83%
6,267,420 $916 Million
Q1 2024

Apr 22, 2024

BUY
$155.22 - $162.74 $50.1 Million - $52.5 Million
322,634 Added 5.32%
6,384,341 $1.01 Billion
Q4 2023

Jan 16, 2024

BUY
$145.6 - $158.88 $3.93 Million - $4.29 Million
26,982 Added 0.45%
6,061,707 $950 Million
Q3 2023

Oct 24, 2023

SELL
$155.75 - $174.48 $29.2 Million - $32.7 Million
-187,448 Reduced 3.01%
6,034,725 $940 Million
Q2 2023

Jul 25, 2023

BUY
$154.35 - $166.11 $20.5 Million - $22 Million
132,557 Added 2.18%
6,222,173 $1.03 Billion
Q1 2023

Apr 14, 2023

BUY
$151.05 - $180.26 $39.6 Million - $47.2 Million
261,975 Added 4.5%
6,089,616 $944 Million
Q4 2022

Feb 08, 2023

BUY
$160.2 - $179.79 $57.6 Million - $64.7 Million
359,785 Added 6.58%
5,827,641 $1.03 Billion
Q3 2022

Oct 25, 2022

BUY
$161.33 - $179.52 $17.4 Million - $19.3 Million
107,613 Added 2.01%
5,467,856 $893 Million
Q2 2022

Aug 12, 2022

BUY
$168.19 - $186.01 $17.9 Million - $19.8 Million
106,194 Added 2.02%
5,360,243 $952 Million
Q1 2022

May 11, 2022

BUY
$158.14 - $179.59 $5.64 Million - $6.4 Million
35,642 Added 0.68%
5,254,049 $931 Million
Q4 2021

Feb 08, 2022

BUY
$155.93 - $173.01 $18.5 Million - $20.5 Million
118,759 Added 2.33%
5,218,407 $893 Million
Q3 2021

Nov 02, 2021

SELL
$161.5 - $179.47 $26.2 Million - $29.1 Million
-162,116 Reduced 3.08%
5,099,648 $824 Million
Q2 2021

Aug 11, 2021

BUY
$159.48 - $171.07 $236 Million - $253 Million
1,477,064 Added 39.03%
5,261,764 $867 Million
Q1 2021

May 14, 2021

SELL
$153.07 - $170.48 $10.5 Million - $11.7 Million
-68,689 Reduced 1.78%
3,784,700 $622 Million
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $22.7 Million - $26 Million
165,219 Added 4.48%
3,853,389 $606 Million
Q3 2020

Nov 04, 2020

BUY
$140.38 - $153.83 $2.43 Million - $2.66 Million
17,275 Added 0.47%
3,688,170 $549 Million
Q2 2020

Jul 28, 2020

BUY
$128.81 - $155.51 $16.6 Million - $20 Million
128,618 Added 3.63%
3,670,895 $516 Million
Q1 2020

Apr 21, 2020

BUY
$111.14 - $153.99 $3.66 Million - $5.07 Million
32,908 Added 0.94%
3,542,277 $465 Million
Q4 2019

Feb 12, 2020

BUY
$127.5 - $146.44 $36.8 Million - $42.3 Million
288,665 Added 8.96%
3,509,369 $512 Million
Q3 2019

Nov 07, 2019

SELL
$126.95 - $142.14 $18.8 Million - $21 Million
-147,789 Reduced 4.39%
3,220,704 $417 Million
Q2 2019

Aug 06, 2019

BUY
$131.15 - $144.24 $4.46 Million - $4.9 Million
33,985 Added 1.02%
3,368,493 $469 Million
Q1 2019

May 06, 2019

SELL
$125.72 - $139.79 $26.1 Million - $29 Million
-207,640 Reduced 5.86%
3,334,508 $466 Million
Q4 2018

Feb 11, 2019

BUY
$122.84 - $147.84 $12.6 Million - $15.1 Million
102,193 Added 2.97%
3,542,148 $457 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $20.2 Million - $23.8 Million
166,366 Added 5.08%
3,439,955 $475 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $21.7 Million - $23.9 Million
181,560 Added 5.87%
3,273,589 $397 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $30.6 Million - $36.2 Million
244,662 Added 8.59%
3,092,029 $396 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $17.2 Million - $18.9 Million
131,429 Added 4.84%
2,847,367 $398 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $9.36 Million - $9.79 Million
72,286 Added 2.73%
2,715,938 $353 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,643,652
2,643,652 $350 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.